cannabis indica

Índice completo — página 66 de 77

Estudos 6.501 a 6.600 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2010 a 2009. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 6.501 a 6.600

  1. 2010

    Disruption of frontal θ coherence by Δ9-tetrahydrocannabinol is associated with positive psychotic symptoms

    DesfavorávelEnsaio Clínico Duplo-CegoPsicoseTHC Farmacêutico
  2. 2010

    Disruption of thermal nociceptive behaviour in mice mutant for the schizophrenia-associated genes NRG1, COMT and DISC1

    FavorávelEstudo em AnimaisEsquizofreniaDor — NociceptivaTetraidrocanabinol (THC)
  3. 2010

    Do Cannabinoids have a therapeutic role in transplantation?

  4. 2010

    Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use

    DesfavorávelMetanálise ClínicaEfeitos Adversos da Cannabis
  5. 2010

    Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study

    DesfavorávelEnsaio Clínico Duplo-CegoPsicoseEsquizofreniaTHC Farmacêutico
  6. 2010

    Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults

    DesfavorávelEnsaio Clínico Duplo-CegoDependência QuímicaDependência — CannabisDepressão
  7. 2010

    Effect of a synthetic cannabinoid agonist on the proliferation and invasion of gastric cancer cells

    FavorávelEstudo LaboratorialCâncerCâncer — EstômagoCanabinoides Sintéticos WIN-x
  8. 2010

    Effect of dietary fat on endocannabinoids and related mediators: Consequences on energy homeostasis, inflammation and mood

  9. 2010

    Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study

    FavorávelEnsaio Clínico Duplo-CegoLesões da Medula EspinhalTetraidrocanabinol (THC)THC Farmacêutico
  10. 2010

    Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations

  11. 2010

    Effects of cannabinoid-receptor antagonists on maintenance and reinstatement of methamphetamine self-administration in rhesus monkeys

  12. 2010

    Efficacy and Tolerability of High-Dose Dronabinol Maintenance in HIV-Positive Marijuana Smokers: A Controlled Laboratory Study.

    FavorávelEnsaio Clínico Duplo-CegoHIV/AIDSTetraidrocanabinol (THC)THC Farmacêutico
  13. 2010

    Endocannabinoid involvement in endometriosis.

  14. 2010

    Endocannabinoids and Schizophrenia

  15. 2010

    Endocannabinoids and their role in fatty liver disease

  16. 2010

    Enhanced Endocannabinoid Signaling Elevates Neuronal Excitability in Fragile X Syndrome

    FavorávelEstudo em AnimaisSíndrome do X Frágil
  17. 2010

    Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: A neuroprotective therapeutic modality

  18. 2010

    Evaluation of the role of striatal cannabinoid CB1 receptors on movement activity of parkinsonian rats induced by reserpine

  19. 2010

    Evidence for a Role of Endocannabinoids, Astrocytes and p38 Phosphorylation in the Resolution of Postoperative Pain

  20. 2010

    Expression and Activity of Fatty Acid Amide Hydrolase in the Colon in Children With Slow Transit Constipation

    InconclusivoEnsaio ClínicoConstipaçãoHidrolase de Amidas de Ácidos Graxos (FAAH)
  21. 2010

    Functional Interactions between Stress and the Endocannabinoid System: From Synaptic Signaling to Behavioral Output

    FavorávelMetanáliseAnandamida (AEA)Endocanabinoide (não especificado)+2
  22. 2010

    GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity?

  23. 2010

    Immunoregulation of a CB2 Receptor Agonist in a Murine Model of NeuroAIDS

    FavorávelEstudo em AnimaisHIV/AIDS
  24. 2010

    Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis

  25. 2010

    Increased cannabinoid receptor 1-immunoreactive nerve fibers in overactive and painful bladder disorders and their correlation with symptoms

    FavorávelEstudo LaboratorialInfecção Urinária
  26. 2010

    Inhibition of monoacylglycerol lipase by troglitazone, N-arachidonoyl dopamine and the irreversible inhibitor JZL184: comparison of two different assays

    InconclusivoEstudo LaboratorialMonoacilglicerol Lipase (MAGL)N-Araquidonoil Dopamina (NADA)
  27. 2010

    Linalool blocks excitability in peripheral nerves and voltage-dependent Na+ current in dissociated dorsal root ganglia neurons

    FavorávelEstudo LaboratorialDor
  28. 2010

    Modulation of risk-taking in marijuana users by transcranial direct current stimulation (tDCS) of the dorsolateral prefrontal cortex (DLPFC)

    DesfavorávelEnsaio ClínicoEfeitos Adversos da CannabisDisfunção Cognitiva
  29. 2010

    Motion Sickness, Stress And The Endocannabinoid System.

  30. 2010

    Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain.

    FavorávelEnsaio Clínico Duplo-CegoDorDor — OncológicaTetraidrocanabinol (THC)
  31. 2010

    Mutations in ABHD12 Cause the Neurodegenerative Disease PHARC: An Inborn Error of Endocannabinoid Metabolism

  32. 2010

    N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor

    InconclusivoEstudo LaboratorialCanabidiol Anormal (Abn-CBD)
  33. 2010

    Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington's disease.

    FavorávelEstudo LaboratorialDoença de HuntingtonCanabinoides Sintéticos HU-x
  34. 2010

    Neuropsychiatric adverse effects signal the end of the line for rimonabant

  35. 2010

    Novel natural and synthetic ligands of the endocannabinoid system

  36. 2010

    Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling

  37. 2010

    Opposite Changes In Cannabinoid CB1 And CB2 Receptor Expression In Human Gliomas

    FavorávelEstudo LaboratorialCâncerCâncer — CérebroCanabinoides Sintéticos WIN-x
  38. 2010

    Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology.

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeTetraidrocanabinol (THC)
  39. 2010

    Oral Delta 9-tetrahydrocannabinol Improved Refractory Gilles De La Tourette Syndrome In An Adolescent By Increasing Intracortical Inhibition: A Case Report

    FavorávelMetanáliseTiques e Síndrome de TouretteTetraidrocanabinol (THC)
  40. 2010

    Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids.

    FavorávelEstudo em AnimaisDoença FalciformeCanabinoides Sintéticos CP-x
  41. 2010

    Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain.

  42. 2010

    Pediatric cannabinoid hyperemesis: two cases

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  43. 2010

    Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol

  44. 2010

    Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials

    FavorávelMetanálise ClínicaDorDor — Neuropatia PeriféricaHIV/AIDS+1
  45. 2010

    Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration

    DesfavorávelEnsaio Clínico Duplo-CegoTHC FarmacêuticoTHC:CBD Farmacêutico
  46. 2010

    Polymorphisms in the endocannabinoid receptor 1 in relation to fat mass distribution

    DesfavorávelEnsaio ClínicoObesidadeDiabetes
  47. 2010

    Potential Role of the Cannabinoid Receptor CB in the Pathogenesis of Erosive and Non-Erosive Gastro-Oesophageal Reflux Disease

    InconclusivoMetanáliseRefluxo Gastroesofágico
  48. 2010

    Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting.

    FavorávelEnsaio Clínico Duplo-CegoNáusea e VômitoNáusea e Vômito por QuimioterapiaTHC:CBD Farmacêutico
  49. 2010

    Psychiatric adverse effects of rimonobant in adults with Prader Willi syndrome

    DesfavorávelEnsaio Clínico Duplo-CegoObesidadeCanabinoide Sintético (não especificado)
  50. 2010

    Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis

    InconclusivoEnsaio Clínico Duplo-CegoEsclerose MúltiplaTHC:CBD Farmacêutico
  51. 2010

    Randomized Placebo-Controlled Double-Blind Clinical Trial of Cannabis-Based Medicinal Product (Sativex) in Painful Diabetic Neuropathy

  52. 2010

    Randomized, controlled, double-blind trial of taranabant for smoking cessation

  53. 2010

    Reduced neural response to reward following 7 days treatment with the cannabinoid CB1 antagonist rimonabant in healthy volunteers

    DesfavorávelEnsaio Clínico Duplo-CegoDepressão
  54. 2010

    Repeated Homotypic Stress Elevates 2-Arachidonoylglycerol Levels and Enhances Short-Term Endocannabinoid Signaling at Inhibitory Synapses in Basolateral Amygdala

    FavorávelEstudo em Animais2-Araquidonoilglicerol (2-AG)
  55. 2010

    Repeated Stress Impairs Endocannabinoid Signaling in the Paraventricular Nucleus of the Hypothalamus

    InconclusivoEstudo em AnimaisCanabinoide Sintético (não especificado)Canabinoides Sintéticos AM-x+1
  56. 2010

    Role of Cannabinoids in the Development of Fatty Liver (Steatosis)

  57. 2010

    Silexan, an Orally Administered Lavandula Oil Preparation, Is Effective in the Treatment of 'Subsyndromal' Anxiety Disorder: A Randomized, Double-Blind, Placebo Controlled Trial

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeInsônia e Distúrbios do Sono
  58. 2010

    Smoked cannabis for chronic neuropathic pain: a randomized controlled trial

    FavorávelEnsaio Clínico Duplo-CegoDorDor — CrônicaDor — Neuropatia PeriféricaTetraidrocanabinol (THC)
  59. 2010

    Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease

  60. 2010

    Structural MRI findings in long-term cannabis users: what do we know?

    DesfavorávelMetanálise ClínicaEfeitos Adversos da Cannabis
  61. 2010

    Systematic review of prospective studies investigating "remission" from amphetamine, cannabis, cocaine or opioid dependence

    DesfavorávelMetanálise ClínicaDependência QuímicaDependência — CannabisDependência — Opioides+2
  62. 2010

    Targeting the Cannabinoid Pathway Limits the Development of Fibrosis and Autoimmunity in a Mouse Model of Systemic Sclerosis

  63. 2010

    Temporal characterization of changes in hippocampal cannabinoid CB1 receptor expression following pilocarpine-induced status epilepticus.

    FavorávelEstudo em AnimaisEpilepsiaCanabinoides Sintéticos WIN-x
  64. 2010

    Tetrahydrocannabinol (THC) For Cramps In Amyotrophic Lateral Sclerosis: A Randomised, Double-blind Crossover Trial

    InconclusivoEnsaio Clínico Duplo-CegoDorEsclerose Lateral Amiotrófica (ELA)Tetraidrocanabinol (THC)
  65. 2010

    THC Prevents MDMA Neurotoxicity in Mice.

  66. 2010

    The cannabis hyperemesis syndrome characterized by persistent nausea and vomiting, abdominal pain, and compulsive bathing associated with chronic marijuana use: a report of eight cases in the United States

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  67. 2010

    The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: anti-invasion activity at low concentration and apoptosis induction at high concentration

    FavorávelEstudo LaboratorialCâncerCâncer — FígadoTetraidrocanabinol (THC)
  68. 2010

    The effects of the synthetic cannabinoid receptor agonists, WIN55,212-2 and CP55,940, on salicylate-induced tinnitus in rats

    InconclusivoEstudo em AnimaisZumbidoCanabinoides Sintéticos WIN-xCanabinoides Sintéticos CP-x
  69. 2010

    The endocannabinoid system and psychiatric disorders.

  70. 2010

    The Endocannabinoid System In The Inflammatory And Neurodegenerative Processes Of Multiple Sclerosis And Of Amyotrophic Lateral Sclerosis

  71. 2010

    The endocannabinoid system links gut microbiota to adipogenesis

  72. 2010

    The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects

    DesfavorávelEnsaio ClínicoEsquizofreniaCBD Farmacêutico
  73. 2010

    The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans

    InconclusivoEnsaio Clínico Duplo-CegoDependência QuímicaDependência — CannabisTetraidrocanabinol (THC)
  74. 2010

    The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes

  75. 2010

    Therapeutic Potential Of Non-Psychotropic Cannabidiol In Ischemic Stroke

    FavorávelMetanáliseDisfunção CognitivaDoença de AlzheimerDoença de Parkinson+3
  76. 2010

    Therapeutical Use Of The Cannabinoids In Psychiatry (Uso Terapêutico Dos Canabinoides Em Psiquiatria)

    FavorávelMetanáliseAnsiedade
  77. 2010

    Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review

    DesfavorávelMetanálise ClínicaDepressãoPsicose
  78. 2010

    Whitening effect of alpha-bisabolol in Asian women subjects

    FavorávelEnsaio ClínicoCâncerDoenças de PeleCâncer — Melanoma+3
  79. 2009

    (Endo)cannabinoids mediate different Ca2+ entry mechanisms in human bronchial epithelial cells

    FavorávelEstudo LaboratorialCanabinoides Sintéticos CP-xVirodamina (O-AEA)
  80. 2009

    2-Arachidonoyl-sn-glycero-3-phosphoinositol: A Possible Natural Ligand for GPR55

    FavorávelEstudo LaboratorialLisofosfatidilinositol (LPI)
  81. 2009

    2-Arachidonoylglycerol Elicits Neuroprotective Effects On Excitotoxically Lesioned Dentate Gyrus Granule Cells Via Abnormal-cannabidiol-sensitive Receptors On Microglial Cells

  82. 2009

    5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats.

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)
  83. 2009

    A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules.

    FavorávelEstudo em AnimaisEsclerose MúltiplaCanabinoides Sintéticos WIN-x
  84. 2009

    A pilot study using nabilone for symptomatic treatment in Huntington's disease.

    FavorávelEnsaio Clínico Duplo-CegoDoença de Huntington
  85. 2009

    A placebo-controlled trial of buspirone for the treatment of marijuana dependence

    InconclusivoEnsaio Clínico Duplo-CegoDependência QuímicaDependência — Cannabis
  86. 2009

    A Population-based Case-Control Study of Marijuana Use and Head and Neck Squamous Cell Carcinoma

    FavorávelMetanáliseCâncerCâncer — Escamoso de Cabeça e Pescoço
  87. 2009

    A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence

    DesfavorávelEnsaio Clínico Duplo-CegoDependência QuímicaDependência — Cannabis
  88. 2009

    A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain

  89. 2009

    Acetylcholinesterase and butyrylcholinesterase inhibitory activity of Pinus species essential oils and their constituents

    FavorávelEstudo LaboratorialDoença de Alzheimer
  90. 2009

    Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers

    InconclusivoEnsaio Clínico Duplo-CegoDepressãoCanabinoide Sintético (não especificado)
  91. 2009

    Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats.

  92. 2009

    Analysis of the effect of neuropeptides and cannabinoids in gastric mucosal defense initiated centrally in the rat

    FavorávelEstudo em AnimaisÚlcera GástricaAnandamida (AEA)Canabinoides Sintéticos WIN-x
  93. 2009

    Antipsychotic effects of cannabidiol.

    FavorávelEnsaio Clínico Duplo-CegoPsicoseEsquizofrenia
  94. 2009

    Apoptosis Induced In HepG2 Cells By The Synthetic Cannabinoid WIN: Involvement Of The Transcription Factor PPARgamma

    FavorávelEstudo LaboratorialCâncerCâncer — FígadoCanabinoides Sintéticos WIN-x
  95. 2009

    Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects

  96. 2009

    Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid Ligands

    FavorávelEstudo LaboratorialObesidadeCanabinoides Sintéticos CP-x
  97. 2009

    Beneficial effects of a Cannabis sativa extract treatment on diabetes-induced neuropathy and oxidative stress

    FavorávelEstudo em AnimaisDorEstresse OxidativoDor — Neuropatia Diabética
  98. 2009

    Bidirectional Regulation Of Novelty-induced Behavioral Inhibition By The Endocannabinoid System

  99. 2009

    Blocking Cannabinoid CB1 Receptors For The Treatment Of Nicotine Dependence: Insights From Pre-clinical And Clinical Studies

  100. 2009

    Caffeine drinking potentiates cannabinoid transmission in the striatum: interaction with stress effects

    FavorávelEstudo em AnimaisEndocanabinoide (não especificado)Medicina Mente-Corpo